The nation of Zimbabwe has rejected a substantial American healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to the United States' request for sensitive information.
This move was revealed after a government memo dated December was disclosed, which showed President Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official spokesman later clarified that the United States was seeking biological samples for research and commercial purposes while refused to share the resulting advantages from future medical innovations.
"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for further talks to reach a agreement agreeable to both sides so the nation's vital HIV programme can be sustained.
Broader Background
This development comes after a similar case in Kenya, where a court halted a related deal with the US following concerns were filed about the security of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had overseen assistance for the US government, but Trump stated its spending was "wasteful" and his government was pursuing government-to-government agreements to enhance openness and accountability.
Based on reports, Sixteen African countries have to date signed these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment through US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"Zimbabwe was being asked to share its genetic material and health information for a long time, with no equivalent guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Put simply, our country would supply the basic resources for scientific discovery with no assurance that the end products would be accessible to our citizens should a future health crisis arise."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks already set up via the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to manage future pandemics.
"This system is designed to guarantee that when a nation provides its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," he added.
"We encourage further dialogue with our US partners on how subsequent co-operation might be designed in a way that honours the sovereignty and dignity of both nations."
Medical Community Reaction
A leading public health body stated it recognised the government's concerns, but suggested that negotiations need to persist since much of the country's Aids initiatives were funded by international support.
"In cases where technical issues arise, such as those involving information security or agreement terms, these can often be resolved through technical clarification and negotiated safeguards," the group added.
The situation highlights the continuing tensions between receiving vital foreign assistance and protecting local interests in an increasingly interconnected world.